New Britain Township Man Wins Biotech Impact Award

DOYLESTOWN, PA — Allen B. Reitz, Ph.D., the Chief Executive Officer of Fox Chase Therapeutics Discovery Inc., has been chosen for the second annual Timothy M. Block, PhD, Biotech Impact Award, announced The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC).

A resident of New Britain Township, Dr. Reitz will receive the award at the 24th Annual Regional Biotechnology Conference at the PABC, which is expected to draw about 100 professionals in the life sciences, finance and related sectors. Daiichi Sankyo of Basking Ridge, N.J., will be the presenting sponsor at this year’s conference.

Proceeds from the event will support research at the nonprofit Hepatitis B Foundation and Blumberg Institute. Details and the registration form are here.

Louis P. Kassa III, MPA, Chief Executive Officer of the PABC, Hepatitis B Foundation and Blumberg Institute, said Dr. Reitz has been one of the most outstanding members of the PABC community for more than a decade.

"Our leadership team chose Dr. Reitz in recognition of his many professional accomplishments, particularly his amazing record of success in the challenging field of drug discovery and development,” Kassa said. “It’s equally important that Dr. Reitz has contributed very significantly as a leader in our community. He’s extremely generous in sharing his time and expertise, and we greatly appreciate the role he plays as one of the senior CEOs at the PABC.”

Located at the PABC, Fox Chase Therapeutics Discovery Inc. (FCTDI) is a science-based small business focused on applying best discovery practices of early-stage drug and probe discovery research to challenges in biomedical research.